Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland

Careful patient selection for wearable cardioverter-defibrillator (WCD) use is crucial, but unfortunately very little information from randomised controlled trials is available to guide clinical decision-making.

Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation

The programmed death-1 (PD-1) pathway serves as a checkpoint to limit T-cell mediated immune responses. Blocking the PD-1 receptor on T cells with monoclonal anti­bodies results in T-cell activation and proliferation and can induce a potent immuno­therapeutic antitumour effect.

Describing adverse events in medical inpatients using the Global Trigger Tool

Improving patient safety in hospitals demands effective and reliable monitoring of adverse events (AEs). The most common method of assessing AEs is retrospective chart review; the Global Trigger Tool is a promising chart review method.

Comment on: Novosel D. Setting as informed consent in psychotherapy. Swiss Med Wkly.2019;149:w20028

Reply to comment by Poppe C on: Novosel D. Setting as informed consent in psychotherapy. Swiss Med Wkly.2019;149:w20028